Top compounds associated with response to IRGC


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA BX-912 GDSC1000 pan-cancer AAC 0.017 0.6
mRNA etoposide GDSC1000 pan-cancer AAC -0.019 0.6
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA PL-DI CTRPv2 pan-cancer AAC -0.017 0.6
mRNA Vorinostat CTRPv2 pan-cancer AAC -0.018 0.6
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.02 0.6
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC -0.029 0.6
mRNA shikonin GDSC1000 pan-cancer AAC -0.018 0.6
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
Download CSV